Skip to main content
The Egyptian Heart Journal

Table 2 The 3-month MACE rate in different subgroups

From: Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

 

MACE −

MACE +

P value

Diabetes mellitus

53 (29.3%)

22 (26.5%)

0.64

Hypertension

64 (35.3%)

40 (48.2%)

0.04

Hyperlipidemia

48 (26.5%)

38 (45.8%)

0.02

Cigarette smoking

48 (26.5%)

24 (28.9%)

0.68

  1. MACE major adverse cardiovascular events
Back to article page